-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Pharmaceutical’s active pharmaceutical ingredients make their debut at the Shanghai API Exhibition.
Category:
Time：2018-04-28
From April 11 to 13, the 80th China API Exhibition was grandly held at the Shanghai International Exhibition Center. Shisi Pharmaceutical Group, which made its debut with specially designed booths featuring its three subsidiaries—Hebei Guolong, Hebei Guangxiang, and Jiangsu Bosheng—received enthusiastic attention from numerous exhibitors and business visitors. In front of the group’s striking and sophisticated special booth, visitors lingered, and customers continuously pointed to the prominently displayed raw materials and medical packaging materials on top of the booth, asking the reception staff about product details: “I’d like to distribute your products wholesale—what are your policies?” Some customers eagerly expressed their intention to establish long-term cooperation with us. From finished dosage forms and raw materials all the way to medical packaging...
From April 11 to 13, the 80th China API Exhibition was grandly held at the Shanghai International Exhibition Center. Shisi Pharmaceutical Group, which made its debut with specially designed booths featuring its three subsidiaries—Hebei Guolong, Hebei Guangxiang, and Jiangsu Bosheng—received enthusiastic attention from numerous participating merchants and guests.
In front of the group’s striking and impressive custom-built booth, visitors and business partners alike stopped to take a closer look. Customers kept pointing to the eye-catching raw materials and medical packaging materials displayed prominently at the top of the booth, asking the reception staff about product details: “I’d like to distribute your products wholesale—what are your policies?” Some customers couldn’t wait to express their eagerness to establish long-term cooperation with us. “From finished dosage forms and raw materials all the way to medical packaging and auxiliary materials, Shisi Pharmaceutical Group has gradually built a relatively complete pharmaceutical industry system. With the strong support of our partners and friends, the company has seen rapid growth in terms of scale, strength, brand recognition, and foreign trade exports,” said General Manager Su Xuejun, Deputy General Manager Wu Hengyao, and Deputy General Manager Li Weimin—leaders of the group—as they warmly introduced the company’s achievements to both new and existing customers and friends who had come to the event.
“This successful participation in the raw-materials expo has laid a solid foundation for the group’s pharmaceutical raw-materials business to achieve significant growth. As Hebei Guangxiang continues to accelerate its development, the company’s enterprise will surely reach a new milestone,” said a senior official from the company with great enthusiasm.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license